Stay updated on Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding and operating status, and updated the page revision information to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T11:38:03.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a 'Show glossary' toggle and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the older 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-28T09:56:21.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page shows a minor revision label update: Revision: v3.3.4 now appears where Revision: v3.3.3 was shown, with no impact on study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:17:30.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer updates include adding Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link along with the prior Revision: v3.3.2 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:19:37.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed and may not all be about the study. Page revision updated to v3.3.2, replacing the older wording about PubMed-derived listings.
    Difference
    0.1%
    Check dated 2025-11-25T11:25:09.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    The government funding lapse notice banner was removed from the page, eliminating the disclaimer about potential information delays. The notice previously warned that information may not be up to date and inquiries could be delayed until appropriations were enacted.
    Difference
    0.4%
    Check dated 2025-11-18T07:01:29.000Z thumbnail image

Stay in the know with updates to Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Metastatic Renal Cell Carcinoma Clinical Trial page.